Go to Courses and units

Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders unit (CSA726)

Location: Online

Introduction

CSA726 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable you to enhance your knowledge in the area of clinical pharmacy and pharmaceutical care. The unit covers the medication management and clinical pharmacy issues in psychiatric and neurological disorders.

Summary

Unit name Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders
Unit code CSA726
Credit points 12.5
College/School Health
School of Pharmacy and Pharmacology
Discipline Pharmacy
Coordinator Doctor Colin Curtain
Delivered By University of Tasmania
Level Postgraduate

Sustainable Development Goals

The Unit Coordinator has identified that this unit aligns with the following UN Sustainable Development Goals. We welcome your thoughts and feedback on the alignment of the unit with these goals.

Availability

Specific information on 2027 unit availability will be available in August

Key Dates

Study Period Start date Census date WW date End date
Semester 2 4/7/2027 26/7/2027 29/8/2027 23/10/2027

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).

Unit census dates currently displaying for 2027 are indicative and subject to change. Finalised census dates for 2027 will be available from the 1st October 2026. Note census date cutoff is 11.59pm AEST (AEDT during October to March).

About Census Dates

Learning Outcomes

  • Create a search strategy to collate evidence-based psychiatric or neurological related research.
  • Critically evaluate and optimise medication therapy in psychiatric and neurological conditions.
  • Apply pharmacotherapeutic knowledge and clinical judgement to clinical scenarios.
  • Communicate evidence-informed decisions in psychiatric and neurological therapeutics.

Fee Information

2027 fee information will be available in August.

Requisites

Concurrent Prerequisites

CSA721 or CSA731

Teaching

Teaching Pattern

Online via MyLO and Online tutorial and meeting rooms.

AssessmentShort Case with Targeted Responses (20%)|Clinical Case Review: Comparative Analysis of Multiple Cases (30%)|Scoping Review Presentation (50%)
TimetableView the lecture timetable | View the full unit timetable

Textbooks

Required

Required readings will be listed in the unit outline prior to the start of classes.

Recommended

It is highly recommended that you study topics relevant to your unit from standard clinical pharmacy texts such as Pharmacotherapy by Joseph T DiPiro 11th Edition OR Applied Therapeutics by Koda-Kimble 11th Edition. There is a wide range of textbooks available online that can be accessed through the UTAS library. 

We assume that Pharmacists undertaking the course will have a general knowledge of most of the therapeutic areas covered, as well as have the necessary skills to interpret laboratory and patient data. Some students may need to refresh and revise this knowledge, due to the many different backgrounds and training that our students have. 

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.